In a patient receiving pramipexole who now shows signs of augmentation, could the worsening be due to a restless‑legs syndrome (RLS) mimic?

Augmentation is the Most Likely Explanation, Not an RLS Mimic

In a patient on pramipexole showing worsening symptoms, augmentation is far more likely than an RLS mimic, but you must systematically exclude mimics through targeted clinical history before attributing symptoms solely to augmentation. 1

Understanding the Clinical Context

Pramipexole causes augmentation in 7-10% of patients annually, making this a common and expected complication rather than an unusual occurrence 2. The 2025 AASM guidelines now explicitly recommend against the standard use of pramipexole for RLS precisely because of this augmentation risk 1.

Why Augmentation is More Likely Than a Mimic

Augmentation Characteristics:

• Symptoms worsen despite continued or increased dopaminergic therapy
• Earlier onset of symptoms in the day (spreading from evening to afternoon or morning)
• Shorter latency to symptom onset when at rest
• Spread of symptoms to previously unaffected body parts (arms, trunk)
• Increased intensity of symptoms
• Shorter duration of medication effect

RLS Mimics to Systematically Exclude:

The 2025 AASM guidelines emphasize that "a careful clinical history is imperative as there is no objective test to aid in making an RLS diagnosis" 1. Specifically evaluate for:

In adults:

• Neuropathy - constant symptoms, not relieved by movement, no circadian pattern
• Akathisia - generalized restlessness, not limb-specific, related to antipsychotic/antiemetic use
• Nocturnal leg cramps - sudden, painful muscle contractions, not an urge to move
• Positional discomfort - relieved by position change alone, not requiring continued movement
• Joint discomfort/arthritis - localized to joints, worse with movement (opposite of RLS)
• Venous stasis/leg edema - visible swelling, no circadian variation
• Spasticity - increased muscle tone, velocity-dependent resistance

1, 3

Diagnostic Approach

Step 1: Verify Original RLS Diagnosis

Confirm the patient met all 5 essential diagnostic criteria initially:

1. Urge to move legs with uncomfortable sensations
2. Symptoms begin/worsen with rest
3. Relief with movement (at least while moving)
4. Worse in evening/night than day
5. Not better explained by another condition

3

Step 2: Characterize the Worsening Pattern

If augmentation:

• Symptoms now occur earlier in the day
• Symptoms spread to new body areas
• Medication effect duration shortened
• Higher doses provide less relief

If a mimic emerged:

• New medical condition developed (diabetes → neuropathy, new medication → akathisia)
• Symptom character changed fundamentally
• Lost circadian pattern or movement-relief pattern

Step 3: Check for Secondary Causes

• Iron studies: Ferritin ≤100 ng/mL or transferrin saturation <20% can worsen RLS 1, 2
• Medication review: New serotonergic antidepressants, dopamine antagonists, or antihistamines 2
• Renal function: End-stage renal disease worsens RLS 1

Management When Augmentation is Confirmed

Immediate Actions:

1. Discontinue pramipexole - taper over 7 days per FDA labeling 4

2. Optimize iron status - treat if ferritin ≤100 ng/mL:

   • Oral ferrous sulfate 325-650 mg daily or every other day 1, 2
   • IV ferric carboxymaltose 1000 mg (strong recommendation, moderate certainty) 1, 2

3. Switch to first-line therapy - The 2025 AASM guidelines now recommend:

   • Gabapentin (strong recommendation) 1
   • Pregabalin (strong recommendation) 1
   • Approximately 70% achieve much/very much improved symptoms vs 40% with placebo 2

4. Consider opioids for severe cases - Extended-release oxycodone or low-dose methadone 5-10 mg daily for augmentation refractory to gabapentinoids 1, 2

Critical Pitfalls to Avoid

• Don't increase pramipexole dose - this worsens augmentation long-term
• Don't switch to another dopamine agonist - cross-augmentation occurs; ropinirole and rotigotine carry the same risk 1
• Don't dismiss iron deficiency - even "low-normal" ferritin (≤100 ng/mL) requires treatment in RLS 2
• Don't restart dopaminergic therapy without physician discussion - withdrawal symptoms can mimic neuroleptic malignant syndrome 4

When to Suspect a True Mimic

Consider a mimic has emerged if:

• Patient develops constant symptoms (not just at rest)
• Symptoms no longer improve with movement
• Lost evening/night predominance completely (rather than spreading to daytime)
• New visible physical findings (edema, joint deformity, skin changes)
• Recent medication changes temporally related to worsening

3

Bottom line: While you must exclude mimics through targeted history, the clinical scenario of worsening on pramipexole strongly suggests augmentation—a well-recognized iatrogenic complication that mandates switching to gabapentinoids as first-line therapy per 2025 guidelines.